Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Nicholas I
Contact Nicholas I, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck RackActions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Articles
Sumoylated Etv1 establishes mouse mammary cancer stem cells that support tumorigenesis by non-stem cancer cells
Keywords mammary oncogenesis stem cells Etv1 sumoylation transcription tumorigenesis cancer stem cell mouse mammary carcinoma neu breast cancer Get full text access Log in, subscribe or purchase for full access. References 1. Siegel, R.L. ∙ Miller, K.D. ∙ Fuchs, H.E. ... Cancer Statistics, 2021 CA Cancer J. Clin. 2021; 71:7-33 2. Colleoni, M. ∙ Munzone, E. Extended adjuvant chemotherapy in endocrine non-responsive disease Breast. 2013; 22:S161-S164 3. Morrow, M.
Antagonistic Roles for MITF and TFE3 in Melanoma Plasticity
Abstract Melanoma cells have the ability to switch from a melanocytic and proliferative state to a mesenchymal and invasive state and back again. This plasticity drives intra-tumoral heterogeneity, progression, and therapeutic resistance. Microphthalmia-associated Transcription Factor (MITF) promotes the melanocytic/proliferative phenotype, but factors that drive the mesenchymal/invasive phenotype and the mechanisms that effect the switch between cell states are unclear.
Actions
Is this you?
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.Get in touch with Nicholas I
Contact Nicholas I, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack